Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 6111407 | UC-112 | 383392-66-3 | 98% |  |
| UC-112 is a novel potent IAP(Inhibitor of apoptosis) inhibitor; potently inhibit cell | ||||
| 611931 | USP7-IN-1 | 1381291-36-6 | 98% | |
| USP7-IN-1 is a novel selective and reversible inhibitor of USP7 with IC50 of 33 uM; l | ||||
| 16071013 | UNC0642 | 1481677-78-4 | 98% by HPLC |  |
| UNC0642 is a potent, selective inhibitor of G9a/GLP with improved PK properties. UNC0 | ||||
| 16070901 | Uprosertib (GSK2141795) | 1047634-65-0 | 98% by HPLC | -cas-1047634-65-0.png) |
| Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailableAktin | ||||
| 011311 | UC-781 | 178870-32-1 | 98% |  |
| UC-781 is a thiocarboxanilide non-nucleoside reverse transcriptase inhibitor. It is a | ||||
| 011123 | UNC1215 | 1415800-43-9 | 98% |  |
| UNC1215 is a potent and selective chemical probe for the methyllysine (Kme) reading f | ||||
| 010440 | U-104 | 178606-66-1 | 98% |  |
| U-104 is a potent carbonic anhydrase (CA) inhibitor for CA IX and CA XII with Ki of 4 | ||||
| 010426 | UMI-77 | 518303-20-3 | 98% |  |
| UMI-77 is a novel selective Mcl-1 SMI inhibitor. UMI-77 binds to the BH3 binding groo | ||||
| 111901 | UNC1999 | 1431612-23-5 | 98% |  |
| UNC1999 is a potent, orally bioavailable and selective inhibitor of EZH2 and EZH1 wit | ||||
| 102201 | U73122 | 112648-68-7 | 98% |  |
| U73122 is a potent phospholipase C (PLC) inhibitor, which reduces agonist-induced Ca2 | ||||
| 101907 | UNBS-5162 | 956590-23-1 | 98% |  |
| UNBS5162 is a novel naphthalimide that binds to DNA by intercalation and suppresses C | ||||
| 82404 | UNC0224 | 1197196-48-7 | 98% |  |
| UNC0224 is a potent and selective G9a inhibitor with IC50 of 15 nM in the G9a Thioglo | ||||
| 82403 | UNC0638 | 1255580-76-7 | 98% |  |
| UNC0638 is an inhibitor of G9a and GLP with excellent potency and selectivity over a | ||||
| 72807 | UNC-2025 | 1429881-91-3 | 97% | |
| UNC-2025 is a novel potent and highly orally bioavailable Mer/FLT3 dual inhibitor, ca | ||||
| 72801 | Umeclidinium bromide | 869113-09-7 | 97% |  |
| Umeclidinium bromide is an anticholinergic drug approved for use in combination with | ||||
| 52738 | UNC2250 | 1493694-70-4 | 98% | |
| UNC2250 is a phosphorylation of endogenous Mer inhibitor with an IC50 of 9.8 nM and b | ||||
| 52710 | UNC0646 | 1320288-17-2 | 98% |  |
| UNC0646 is a potent and selective G9a inhibitor with IC50 of 6 nM. | ||||
| 52709 | UNC 0631 | 1320288-19-4 | 98% |  |
| UNC 0631 is a potent G9a inhibitor with IC50 value of 4 nM. | ||||
| 52708 | UNC0321 | 1238673-32-9 | 98% |  |
| UNC0321 is a potent and selective G9a inhibitor with Ki of 63 pM, UNC0321 is the firs | ||||
| 52574 | UNC2881 | 1493764-08-1 | 98% | |
| UNC2881 is a potent and specific Mer kinase inhibitor; inhibits steady-state Mer kina | ||||
| 52214 | UNC0064-12 | 1430089-64-7 | 98% |  |
| UNC0064-12 is useful chemical agent for research use. | ||||
| 51801 | UNC0379 | 1620401-82-2 | 98% |  |
| UNC0379 is a selective, substrate competitive inhibitor ofN-lysine methyltransferase | ||||